Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001765581-25-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-03 | 2025-02-27 | JAZZ | Johnson Philip L | EVP, CFO | A - Grant | $0.00 | +23.1K | 51.2K | +82% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-02-27 | A | A | 15,407 | $0.00 | 43,505 | D | — | — | (F2) The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024. |
| 2 | Common | Ordinary Shares | 2025-02-27 | A | A | 7,704 | $0.00 | 51,209 | D | — | — |